Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Journal of Bacteriology|July 3, 2003
Mechanisms of activation of phosphoenolpyruvate carboxykinase from Escherichia coli by Ca2+ and of desensitization by trypsinAthena Sudom, Robert Walters, Landon Pastushok, et al.Structure (London, England : 1993)|December 13, 2006
Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeperZhulun Wang, Jinsong Liu, Athena Sudom, et al.The Journal of Biological Chemistry|January 1, 2022
Development of a potent high-affinity human therapeutic antibody via novel application of recombination signal sequence-based affinity maturationAgnieszka Kielczewska, Igor D'Angelo, Maria Sheena Amador, et al.The Journal of Biological Chemistry|June 22, 2012
Structure of the nuclear factor κB-inducing kinase (NIK) kinase domain reveals a constitutively active conformationJinsong Liu, Athena Sudom, Xiaoshan Min, et al.Iscience|December 8, 2021
Next generation Fc scaffold for multispecific antibodiesBram Estes, Athena Sudom, Danyang Gong, et al.Chemical Biology & Drug Design|December 12, 2007
Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitorClarence Hale, Murielle Véniant, Zhulun Wang, et al.Bioorganic & Medicinal Chemistry Letters|May 31, 2008
Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1)Daqing Sun, Zhulun Wang, Yongmei Di, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11beta-HSD1 inhibitorsYosup Rew, Dustin L McMinn, Zhulun Wang, et al.Bioorganic & Medicinal Chemistry Letters|November 4, 2015
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4Zhulun Wang, Daqing Sun, Sheree Johnstone, et al.Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Identification of a PPARdelta agonist with partial agonistic activity on PPARgammaRichard V Connors, Zhulun Wang, Martin Harrison, et al.Pageof 3